SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,450,353 | +16.7% | 944,852 | +5.9% | 0.04% | +18.2% |
| Q2 2023 | $171,765,931 | -6.1% | 892,476 | -1.2% | 0.03% | -8.3% |
| Q1 2023 | $182,893,378 | +59.9% | 903,311 | +1.5% | 0.04% | +50.0% |
| Q4 2022 | $114,402,558 | -4.2% | 890,223 | +2.0% | 0.02% | -11.1% |
| Q3 2022 | $119,475,000 | -25.2% | 873,162 | -3.3% | 0.03% | -20.6% |
| Q2 2022 | $159,705,000 | +15.0% | 902,591 | -6.4% | 0.03% | +41.7% |
| Q1 2022 | $138,881,000 | -5.7% | 964,120 | +1.2% | 0.02% | 0.0% |
| Q4 2021 | $147,348,000 | -9.4% | 953,084 | -0.5% | 0.02% | -17.2% |
| Q3 2021 | $162,589,000 | +16.9% | 957,539 | +8.7% | 0.03% | +16.0% |
| Q2 2021 | $139,091,000 | +16.6% | 880,997 | +2.6% | 0.02% | +13.6% |
| Q1 2021 | $119,257,000 | -19.7% | 858,828 | +1.2% | 0.02% | -24.1% |
| Q4 2020 | $148,576,000 | – | 848,327 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |